Letters Drug companies and the public

EC proposal can be defeated

BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b291 (Published 28 January 2009) Cite this as: BMJ 2009;338:b291
  1. Don Redding, head of policy1
  1. 1Picker Institute Europe, Oxford OX1 1RX
  1. don.redding{at}pickereurope.ac.uk

    Although it remains worrying, the European Commission’s proposal for greater freedom for pharmaceutical companies to communicate directly to patients about prescription drugs has already been significantly watered down, and can still be defeated.1 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe